|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C,
Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kirson ED, Dbalý V, Tovaryš F, Vymazal J,
Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S,
Gurvich Z, Schneiderman R, et al: Alternating electric fields
arrest cell proliferation in animal tumor models and human brain
tumors. Proc Natl Acad Sci USA. 104:10152–10157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gilbert MR, Wang M, Aldape KD, Stupp R,
Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT,
et al: Dose-dense temozolomide for newly diagnosed glioblastoma: A
randomized phase III clinical trial. J Clin Oncol. 31:4085–4091.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Taillibert S, Kanner AA, Kesari
S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink
KL, et al: Maintenance therapy with Tumor-treating fields plus
temozolomide vs. temozolomide alone for glioblastoma: A randomized
clinical trial. JAMA. 314:2535–2543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Toms SA, Kim CY, Nicholas G and Ram Z:
Increased compliance with tumor treating fields therapy is
prognostic for improved survival in the treatment of glioblastoma:
A subgroup analysis of the EF-14 phase III trial. J Neurooncol.
141:467–473. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ballo MT, Conlon P, Lavy-Shahaf G, Kinzel
A, Vymazal J and Rulseh AM: Association of Tumor Treating Fields
(TTFields) therapy with survival in newly diagnosed glioblastoma: A
systematic review and meta-analysis. J Neurooncol. 164:1–9. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pena LC, Anderson C, Agarwal MS, Galvan E,
Kelly W and Wagner TD: Retrospective review of the factors limiting
optune initiation in GBM patients. Int J Radiat Oncol. 117:e932023.
View Article : Google Scholar
|
|
8
|
Higa N, Akahane T, Yokoyama S, Yonezawa H,
Uchida H, Takajo T, Kirishima M, Hamada T, Matsuo K, Fujio S, et
al: A tailored next-generation sequencing panel identified distinct
subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer
Sci. 111:3902–3911. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Parry R, Macias Soria S, Pradat-Diehl P,
Marchand-Pauvert V, Jarrassé N and Roby-Brami A: Effects of hand
configuration on the grasping, holding, and placement of an
instrumented object in patients with hemiparesis. Front Neurol.
10:2402019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goh LY, Tan IO, Yang LC and Ng SSM:
Effects of cognitive and motor tasks on the walking speed of
individuals with chronic stroke. Medicine (Baltimore).
96:e62322017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dehnavi AZ, Zhang-James Y, Draytsel D,
Carguello B, Faraone SV and Weinstock RS: Association of ADHD
symptoms with type 2 diabetes and cardiovascular comorbidities in
adults receiving outpatient diabetes care. J Clin Transl
Endocrinol. 32:1003182023.PubMed/NCBI
|
|
13
|
DeVettori G, Troxel WM, Duff K and Baron
KG: Positive airway pressure adherence among patients with
obstructive sleep apnea and cognitive impairment: A narrative
review. Sleep Med. 111:28–35. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Dube C, Gibert MJ, Cruickshanks
N, Wang B, Coughlan M, Yang Y, Setiady I, Deveau C, Saoud K, et al:
The p53 pathway in glioblastoma. Cancers (Basel). 10:2972018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park AK, Kim P, Ballester LY, Esquenazi Y
and Zhao Z: Subtype-specific signaling pathways and genomic
aberrations associated with prognosis of glioblastoma. Neuro Oncol.
21:59–70. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
NCCN Clinical Practice Guidelines in
Oncology, . Central Nervous System Cancers. Version 2.2021.
National Comprehensive Cancer Network; Plymouth Meeting, PA:
Available at:. https://www.nccn.org/professionals/physician_gls/pdf/cns.pdfAugust
18–2025
|
|
17
|
Takido Y, Ohka F, Deguchi S, Motomura K,
Mitsuya K, Aoki K, Shiba Y, Takeuchi K, Nagata Y, Yamaguchi J, et
al: Distant parenchymal recurrence during long-term use of TTFields
treatment for glioblastoma. Int J Clin Oncol. 30:1309–1318. 2025.
View Article : Google Scholar : PubMed/NCBI
|
